Tuesday, March 17, 2026

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

THE KOREAN WAR IS OVER! Did Seoul Just Concede Defeat To North Korea By Offering MDL Talks?

South Korea proposes inter-Korean military talks to clarify the MDL, aiming to reduce tensions and prevent accidental clashes.

Sung Chul Shin

South Korea Emerges as Key Ally in U.S. Navy’s $1 Trillion Fleet Expansion

The U.S. plans to invest $1 trillion over 30 years to expand its naval fleet, emphasizing the need for alliances like South Korea.

Top News

- Our Sponsors Ad -

Follow us